Readers have responded to a recent article on hypermobile Ehlers-Danlos syndrome (hEDS) with urgent calls for action, describing a systemic public health catastrophe that leaves lives in ruins. One 34-year-old former drama student detailed how hEDS dismantled her life, making friendships and relationships extremely difficult. Her decline began at 19 with surgeries; by 24, she was diagnosed with thyroid cancer and Hashimoto’s, and had a Beighton score of 9/9, indicating extreme hypermobility.
Chronic Pain and Nervous System Instability
For eight years, her nervous system has been so unstable that she has frequently been unable to read, watch TV, or tolerate light. At her lowest, she could not spell basic words or speak in coherent sentences. She spent her life seeking answers, with diagnoses coming from private specialists in England, not the NHS in Scotland. Her parents spent thousands on her care, and without this financial lifeline, she believes she might be in a wheelchair. She asks: 'What becomes of those with nothing?'
Systemic Failures in Diagnosis and Treatment
Despite clear evidence, the NHS never suggested testing for comorbidities like postural orthostatic tachycardia syndrome (POTS) or mast cell activation syndrome (MCAS). This is the norm: 94.4% of hEDS patients endure psychiatric misdiagnosis before clarity. The condition carries a disability burden comparable to multiple sclerosis, yet receives a fraction of the funding. With 90% of cases being women facing 15-year diagnostic delays and a 17.8% suicide-attempt rate, readers demand an urgent formal review and immediate investment in dedicated research.
Diagnosis Without Treatment Plan
Another reader shared that her daughter was diagnosed within 15 years, but only after the family made securing a diagnosis a full-time job. A consultant remarked almost as a footnote that it might be hEDS, but nothing happened afterward. The daughter, now 34, is in constant pain, managing her condition with exercise, diet, supplements, and prolonged rest. Her life is often at a standstill. The reader concludes: 'A diagnosis is very helpful, but not when it isn’t accompanied by a treatment plan.'
Hidden Crisis of Unprecedented Scale
With prevalence estimated at one in 227 people in the UK and 95% of sufferers remaining undiagnosed, readers warn we are seeing only the tip of the iceberg. Without action, how many more lives will be ruined? The letters highlight a brutal reality: those without financial means may face even worse outcomes. The call is clear: immediate investment in research and a formal review of hEDS care are desperately needed.
